Nivolumab plus chemotherapy or ipilimumab versus chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma: 5-year follow-up results from CheckMate 648

Annals of Vascular Surgery · Elsevier

Аннотация

Publication date: November 2026 Source: Annals of Oncology, Volume 37, Issue 11 Author(s): K. Kato, J. Ajani, Y. Doki, J. Xu, L. Wyrwicz, S. Motoyama, T. Ogata, H. Kawakami, C.-H. Hsu, A. Adenis, F. el Hajbi, M. Di Bartolomeo, M. Ignez Braghiroli, E. Holtved, T. Makino, M. Blum Murphy, J. Zhang, P. Sharma, B. He, M. Lei

Читать у издателя →

Похожие статьи